The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease (Q39136811)
Jump to navigation
Jump to search
scientific article published on 2 May 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease |
scientific article published on 2 May 2014 |
Statements
1 reference
The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease (English)
1 reference
1 reference
Ted M Dawson
1 reference
Senthilkumar S Karuppagounder
1 reference
Saurav Brahmachari
1 reference
Valina L Dawson
1 reference
Han Seok Ko
1 reference
1 reference
Identifiers
1 reference